Safety data sheet

Safety data sheet according to Regulation (EC) No 1907/2006, Annex II
Revised on / Version: 15.12.2014 / 0003
Replaces revision of / Version: 11.01.2013 / 0002
Valid from: 15.12.2014
PDF print date: 16.12.2014
26033 TESLANOL T71 Kältespray 200 ml
26034 TESLANOL T71 Kältespray 400 ml
10.3 Possibility of hazardous reactions
See also Subsection 10.1 to 10.6.
Possible build up of explosive/highly flammable vapour/air mixture.
10.4 Conditions to avoid
See also section 7.
Heating, open flame, ignition sources
Pressure increase will result in danger of bursting.
10.5 Incompatible materials
Avoid contact with strong oxidizing agents.
10.6 Hazardous decomposition products
See also Subsection 10.1 to 10.5.
No decomposition when used as directed.
SECTION 11: Toxicological information
Possibly more information on health effects, see Section 2.1 (classification).
26033 TESLANOL T71 Kältespray 200 ml
26034 TESLANOL T71 Kältespray 400 ml
Toxicity/effect Endpoi
nt
Value Unit Organism Test method Notes
Acute toxicity, by oral route: n.d.a.
Acute toxicity, by dermal
route:
n.d.a.
Acute toxicity, by inhalation: n.d.a.
Skin corrosion/irritation: n.d.a.
Serious eye
damage/irritation:
n.d.a.
Respiratory or skin
sensitisation:
n.d.a.
Germ cell mutagenicity: n.d.a.
Carcinogenicity: n.d.a.
Reproductive toxicity: n.d.a.
Specific target organ toxicity -
single exposure (STOT-SE):
n.d.a.
Specific target organ toxicity -
repeated exposure (STOT-
RE):
n.d.a.
Aspiration hazard: n.d.a.
Respiratory tract irritation: n.d.a.
Repeated dose toxicity: n.d.a.
Symptoms: n.d.a.
Other information: Classification according
to calculation
procedure.
Butane
Toxicity/effect Endpoi
nt
Value Unit Organism Test method Notes
Acute toxicity, by inhalation: LC50 658 mg/l/4h Rat
Germ cell mutagenicity: OECD 471 (Bacterial
Reverse Mutation
Test)
Negative
Symptoms: ataxia, breathing
difficulties, drowsiness,
unconsciousness,
frostbite, disturbed
heart rhythm,
headaches, cramps,
intoxication, dizziness,
nausea and vomiting.
Propane
Page 6 of 11